Correlation Between Biofrontera Warrants and Silence Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Silence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Silence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Silence Therapeutics PLC, you can compare the effects of market volatilities on Biofrontera Warrants and Silence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Silence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Silence Therapeutics.

Diversification Opportunities for Biofrontera Warrants and Silence Therapeutics

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Biofrontera and Silence is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Silence Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silence Therapeutics PLC and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Silence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silence Therapeutics PLC has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Silence Therapeutics go up and down completely randomly.

Pair Corralation between Biofrontera Warrants and Silence Therapeutics

Assuming the 90 days horizon Biofrontera Warrants is expected to generate 40.34 times more return on investment than Silence Therapeutics. However, Biofrontera Warrants is 40.34 times more volatile than Silence Therapeutics PLC. It trades about 0.19 of its potential returns per unit of risk. Silence Therapeutics PLC is currently generating about -0.04 per unit of risk. If you would invest  2.21  in Biofrontera Warrants on September 2, 2024 and sell it today you would earn a total of  10.79  from holding Biofrontera Warrants or generate 488.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy62.5%
ValuesDaily Returns

Biofrontera Warrants  vs.  Silence Therapeutics PLC

 Performance 
       Timeline  
Biofrontera Warrants 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera Warrants are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Biofrontera Warrants showed solid returns over the last few months and may actually be approaching a breakup point.
Silence Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silence Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Biofrontera Warrants and Silence Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofrontera Warrants and Silence Therapeutics

The main advantage of trading using opposite Biofrontera Warrants and Silence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Silence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will offset losses from the drop in Silence Therapeutics' long position.
The idea behind Biofrontera Warrants and Silence Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities